International Immunology, Vol. 14, No. 8, pp. 839-848,
August 2002
© 2002 Japanese Society for Immunology
Isoforms of the class II transactivator protein
1 INSERM U396, Centre de Recherches Biomédicales des Cordeliers and Laboratoire d’Immunologie et d’Histocompatibilité, APHP, Hôpital St Louis, 75270 Paris, France 2 INSERM U429, Hôpital Necker Enfants-Malades, 75015 Paris, France 3 Departamento de Biologia, Facultad de Ciencias, Universidad de Chile, Santiago, Chile 4 Permanent address: Istituto di Biologia dello Sviluppo, CNR, 90146 Palermo, Italy
V. D. and T. P. contributed equally to this work and are considered as second co-authors
Correspondence to: C. Alcaïde-Loridan, INSERM U396, Centre de Recherches Biomédicales des Cordeliers, 15 rue de l‘Ecole de Médecine, 75270 Paris Cedex 06, France. E-mail: Catherine.Alcaide{at}bhdc.jussieu.fr
Transmitting editor: G. Hämmerling
The class II transactivator (CIITA) controls both the constitutive and IFN-
inducible expression of HLA-D genes. In addition, through the squelching of another transactivator CREB-binding protein, CIITA was more recently shown to have a wider cellular function, including cell cycle control or cellular response to IFN- and IL-4. However, due to its low expression level, its analysis mainly relies on the study of recombinant overexpressed forms of the protein. We report here the analysis of native CIITA in various cell types. We first show the precise timing of CIITA protein expression in a fibroblast cell line in response to IFN-. This expression is observed 2 h after the cytokine addition with a peak of expression ranging from 16 to 24 h. We next show the existence of two major isoforms of the CIITA protein differentially expressed in fibroblast, B lymphocyte or melanoma cell lines. We present the first demonstration that these isoforms originate from alternative translation initiation codons. We finally show that CIITA isoforms translocate to the nucleus with an apparently similar efficiency. Our data therefore demonstrate the existence of CIITA isoforms whose respective ratio depends on the cell type examined. However, we present evidence for a modulation of this ratio in a melanoma cell line with an abnormal constitutive expression of MHC class II molecules.
Keywords: gene regulation, HLA, melanoma, MHC, promoter, transcription
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. Arakaki, A. Nagaoka, N. Ishimaru, A. Yamada, S. Yoshida, and Y. Hayashi Role of Plasmacytoid Dendritic Cells for Aberrant Class II Expression in Exocrine Glands from Estrogen-Deficient Mice of Healthy Background Am. J. Pathol., May 1, 2009; 174(5): 1715 - 1724. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Buttice, J. Miller, L. Wang, and B. D. Smith Interferon-{gamma} Induces Major Histocompatibility Class II Transactivator (CIITA), Which Mediates Collagen Repression and Major Histocompatibility Class II Activation by Human Aortic Smooth Muscle Cells Circ. Res., March 3, 2006; 98(4): 472 - 479. [Abstract] [Full Text] [PDF]
|
|